Improving informed consent in clinical trials: A duty to experiment

被引:63
|
作者
Lavori, PW
Sugarman, J
Hays, MT
Feussner, JR
机构
[1] Palo Alto VAHCS, Dept Vet Affairs, Cooperat Studies Program Coordinating Ctr, Palo Alto, CA USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Biostat, Stanford, CA 94305 USA
[3] Palo Alto VAHCS, Nucl Med Serv, Palo Alto, CA USA
[4] Duke Univ, Med Ctr, Durham VAMC, Div Gen Internal Med, Durham, NC USA
[5] Duke Univ, Dept Philosophy, Durham, NC USA
[6] Duke Univ, Dept Vet Affairs, Off Res & Dev, Durham, NC USA
来源
CONTROLLED CLINICAL TRIALS | 1999年 / 20卷 / 02期
关键词
informed consent; randomized clinical trials; ethics; research ethics;
D O I
10.1016/S0197-2456(98)00064-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Practitioners of clinical trials have a responsibility to ensure that patients' participation in research be informed and voluntary. This responsibility implies that we should strive continuously to improve the effectiveness of methods for informing prospective research volunteers about experimental studies, thereby enhancing the protection of their interests. We should test innovations in informed consent in realistic contexts (i.e., in clinical trials) and with randomization when it is appropriate, at the first opportunity. In this study, we develop a preliminary proposal to improve the quality of informed consent, based on experimentation with informed consent in ongoing clinical trials. We discuss the conceptual, ethical, organizational, and technical bases for such an effort. Controlled Clin Trials 1999;20:187-193. (C) Elsevier Science Inc. 1999.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 50 条
  • [11] Clinical trials in the time of a pandemic: implications for informed consent
    Palazzani, Laura
    BIOLAW JOURNAL-RIVISTA DI BIODIRITTO, 2021, (02): : 35 - 50
  • [12] IMPROVING CLINICAL COMMUNICATION: A QUALITATIVE STUDY ON THE INFORMED CONSENT
    Garcia-Izquierdo, Isabel
    Belles-Fortuno, Begona
    REVISTA DE LINGUISTICA Y LENGUAS APLICADAS, 2024, 19 : 71 - 83
  • [13] INFORMED CONSENT IN CLINICAL TRIALS: PERCEPTIONS AND EXPERIENCES OF A SAMPLE OF SOUTH AFRICAN RESEARCHERS
    van Loon, Katherine
    Lindegger, Graham
    HEALTH SA GESONDHEID, 2009, 14 (01):
  • [14] Clinical Informed Consent and ABA
    Graber, Abraham
    Maguire, Allison
    BEHAVIOR ANALYSIS IN PRACTICE, 2024, 17 (02) : 389 - 400
  • [15] Informed consent in clinical medicine
    Terry, Peter B.
    CHEST, 2007, 131 (02) : 563 - 568
  • [16] INFORMED CONSENT IN CLINICAL RESEARCH WITH DRUGS IN SPAIN - PERSPECTIVE OF CLINICAL-TRIALS COMMITTEE MEMBERS
    DALRE, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (04) : 319 - 324
  • [17] Informed consent and assent guide for paediatric clinical trials in Europe
    Lepola, Pirkko
    Kindred, Maxine
    Giannuzzi, Viviana
    Glosli, Heidi
    Dehlinger-Kremer, Martine
    Dalrymple, Harris
    Neubauer, David
    Boylan, Geraldine B.
    Conway, Jean
    Dewhurst, Jo
    Hoffman, Diane
    ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (06) : 582 - 590
  • [18] Women's autonomy and informed consent in microbicides clinical trials
    Woodsong, Cynthia
    MacQueen, Kathleen
    Namey, Emily
    Sahay, Seema
    Morar, Neetha
    Mlingo, Margaret
    Mehendale, Sanjay
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2006, 1 (03) : 11 - 26
  • [19] Patients' perception of the informed consent process for neurooncology clinical trials
    Knifed, Eva
    Lipsman, Nir
    Mason, Warren
    Bernstein, Mark
    NEURO-ONCOLOGY, 2008, 10 (03) : 348 - 354
  • [20] Informed consent in clinical trials: technicalities, trust and intimate relationships
    Wadmann, Sarah
    ETIKK I PRAKSIS, 2013, 7 (02): : 31 - 46